Eyecare biotech jumps 19% after stablecoin-focused rebrand
Eyecare biotech company has seen its stock price surge by 19% following a rebranding effort that shifts its focus towards stablecoin technology. The company aims to leverage blockchain solutions to enhance its operations and financial stability. This strategic pivot is expected to attract new investors and partnerships within the cryptocurrency sector. Analysts suggest that the rebrand could position the company favorably in the evolving digital finance landscape.
Read the full article: Coin Telegraph